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The Safe Start trial to assess the effect of
an infant hygiene intervention on enteric
infections and diarrhoea in low-income
informal neighbourhoods of Kisumu, Kenya:
a study protocol for a cluster randomized
controlled trial
Jane Mumma1*† , Sheillah Simiyu2, Evalyne Aseyo1, John Anderson3, Alexandra Czerniewska5, Elizabeth Allen4,
Robert Dreibelbis5, Kelly K. Baker6 and Oliver Cumming5*†
Abstract
Background: Symptomatic and asymptomatic enteric infections in early childhood are associated with negative
effects on childhood growth and development, especially in low and middle-income countries, and food may
be an important transmission route. Although basic food hygiene practices might reduce exposure to faecal
pathogens and resulting infections, there have been few rigorous interventions studies to assess this, and no
studies in low income urban settings where risks are plausibly very high. The aim of this study is to evaluate the
impact of a novel infant food hygiene intervention on infant enteric infections and diarrhoea in peri-urban
settlements of Kisumu, Kenya.
Methods: This is a cluster randomized control trial with 50 clusters, representing the catchment areas of
Community Health Volunteers (CHVs), randomly assigned to intervention or control, and a total of 750 infants
recruited on a rolling basis at 22 weeks of age and then followed for 15 weeks. The intervention targeted four
key caregiver behaviours related to food hygiene: 1) hand washing with soap before infant food preparation and
feeding; 2) bringing all infant food to the boil before feeding, including when reheating or reserving; 3) storing all
infant food in sealed containers; and, 4) using only specific utensils for infant feeding which are kept separate and
clean.
Results: The primary outcome of interest is the prevalence of one or more of 23 pre-specified enteric infections,
determined using quantitative real-time polymerase chain reaction for enteric pathogen gene targets. In addition,
infant food samples were collected at 33 weeks, and faecal indicator bacteria (Enterococcus) isolated and
enumerated to assess the impact of the intervention on infant food contamination.
(Continued on next page)
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: jnmumma@gmail.com; Oliver.Cumming@lshtm.ac.uk
†Jane Mumma and Oliver Cumming contributed equally to this work.
1Center of Research, Great Lakes University Kisumu, P.O. Box 2224-40100,
Kisumu, Kenya
5Disease Control Department, London School of Hygiene and Tropical
Medicine, WC1E 7HT, London, UK
Full list of author information is available at the end of the article
Mumma et al. BMC Infectious Diseases         (2019) 19:1066 
https://doi.org/10.1186/s12879-019-4657-0
(Continued from previous page)
Conclusion: To our knowledge this is the first randomized controlled trial to assess the effect of an infant food
hygiene intervention on enteric infections in a high burden, low income urban setting. Our trial responds to
growing evidence that food may be a key pathway for early childhood enteric infection and disease and that basic
food hygiene behaviours may be able to mitigate these risks. The Safe Start trial seeks to provide new evidence as
to whether a locally appropriate infant food hygiene intervention delivered through the local health extension
system can improve the health of young children.
Trial registration: The trial was registered at clinicaltrial.gov on March 16th 2018 before enrolment of any
participants (https://clinicaltrials.gov/ct2/show/NCT03468114).
Keywords: Enteric infections, Diarrhoea, Child food, Infant food, Hygiene, Kenya, Kisumu
Background
Diarrhoeal disease, a key symptom of gastro-intestinal or
enteric infection, is the fourth leading cause of disability
globally [1] and the leading cause of child death in sub-
Saharan Africa [2]. Furthermore, there is growing evi-
dence of the impact of sub-clinical childhood enteric in-
fection and disease on growth and development [3, 4].
Food is likely to be an important source of exposure to
enteric pathogens in early childhood. Recent studies
have shown that food given to children in early child-
hood can be highly contaminated with faecal indicator
bacteria [5] as well as specific diarrhoeagenic enteric
pathogens [6]. Environmental interventions to reduce
exposure to these pathogens and reduce diarrhoea have
traditionally focused on improving the quality and distri-
bution of drinking water, the management of excreta
through sanitation systems and the promotion of hand-
washing with soap at critical times [7] but generally not
on food hygiene related behaviours and infrastructure.
More than half of the world’s population now reside in
urban areas and over one third of this population live in
‘slums or informal settlements’ [8]. Although access to
safe water and sanitation is generally higher in urban
areas [9], the risk of enteric infection may be greatest in
poor urban areas due to the combination of high popu-
lation density and limited public health infrastructure
[10–13]. These conditions pose multiple risks for con-
tamination of food as supported by a recent study of
pathogen diversity in infant food in low-income informal
neighbourhoods of Kisumu, Kenya [6]. The ‘Safe Start’
trial is designed to assess whether a locally appropriate,
low-cost food hygiene intervention, delivered within the
context of the existing health extension system in peri-
urban neighbourhoods of Kisumu, Kenya can reduce
early childhood exposure to enteric pathogens.
Methods
Research aim and objectives
The purpose of this study is to examine the effect of an
infant food hygiene behaviour change intervention on
child health. The study will assess the impact of the
intervention on: (1) infant health as determined by
prevalence of gastro-intestinal infection and diarrhoeal;
(2) specific food hygiene practices; and (3) infant food
contamination.
Study design
Our study was a cluster randomized controlled trial
(cRCT) design. Clusters for the trial were defined as the
catchment areas of local Community Health Volunteers
(CHVs); a total of 50 CHV catchment areas were re-
cruited into the study and randomly assigned to an
intervention and control arm of the study. An overview
of the study design is presented in Fig. 1 (CONSORT
[14] diagram).
The primary outcome for the study is the preva-
lence of enteric infection at age 37 weeks (+/− 1
week). We define the prevalence of enteric infection
as the presence of 1 or more enteric pathogens in
child stools based on the detection of 23 genetic
markers of specific common enteric bacteria, viruses
and protozoan (Table 1). The secondary outcome is
diarrhoea; defined as the number of days a child has
diarrhoea between 22 and 37 weeks of age (+/− 1
week). Tertiary outcomes include child mortality, de-
fined as any infant death occurring between 22 and
37 weeks of age (+/− 1 week). In addition, the study
will assess the effectiveness of the intervention by
measuring changes in specific food practices and in
bacterial contamination of infant food.
Study setting
The study is being conducted in two informal neigh-
bourhoods of Kisumu, Kenya: Nyalenda A and Nyalenda
B (Fig. 2). Kisumu is the third largest city in Kenya and
is located in Kisumu County, on the shores of Lake
Victoria, and has a population of approximately 400,000.
The city is surrounded by a series of peri-urban areas
sometimes referred to as the ‘slum belt’ [15]. These peri-
urban areas have emerged due to economic migration
and a lack of affordable housing [16]. Some sources
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estimate that up to 60% of the city’s population reside in
these peri-urban communities [17].
The counties that previously made up the Nyanza and
Western provinces have relatively high levels of
infectious disease morbidity and mortality. The child
mortality rate for Kisumu county is 105 deaths per 1000
live births and the prevalence of childhood stunting
(below-2 SD) is approximately 25% [18]. In Kisumu
Table 1 – Specific enteric pathogen primers and probes for TaqMan Array Card used to determine the primary outcome
PATHOGEN GENE TARGET FORWARD PRIMER REVERSE PRIMER PROBE SEQUENCE Ref
BACTERIA
Aeromonas Aerolysin TYCGYTACCAGTGGGACAAG CCRGCAAACTGGCTCTCG CAGTTCCAGTCCCACCACTT [2]
Campylobacter jejuni/
C. coli
cadF CTGCTAAACCATAGAAATAAAA
TTTCTCAC
CTTTGAAGGTAATTTAGATATG
GATAATCG
CATTTTGACGATTTTTGGCTTGA [2]
Clostridium difficile tcdB GGTATTACCTAATGCTCCAAATAG TTTGTGCCATCATTTTCTAAGC CCTGGTGTCCATCCTGTTTC [2]
Enteroaggregative
Escherichia coli (EAEC)
aaiC ATTGTCCTCAGGCATTTCAC ACGACACCCCTGATAAACAA TAGTGCATACTCATCATTTAAG [2]
Enteroaggregative
Escherichia coli (EAEC)
aatA CTGGCGAAAGACTGTATCAT TTTTGCTTCATAAGCCGATAGA TGGTTCTCATCTATTACAGACA
GC
[2]
Enterohemorrhagic E.
coli (EHEC) 0157
rdbE TTTCACACTTATTGGATGGTCTCAA CGATGAGTTTATCTGCAAGGTGAT CTCTCTTTCCTCTGCGGTCCT [1]
Enteropathogenic
E. coli (EPEC)
eae CATTGATCAGGATTTTTCTGGTGATA CTCATGCGGAAATAGCCGTTA ATACTGGCGAGACTATTTCAA [2]
Enteropathogenic
E. coli (EPEC)
bfpA TGGTGCTTGCGCTTGCT CGTTGCGCTCATTACTTCTG CAGTCTGCGTCTGATTCCAA [2]
Enterotoxigenic
E. coli (ETEC) LT toxin
ETEC LT TTCCCACCGGATCACCAA CAACCTTGTGGTGCATGATGA CTTGGAGAGAAGAACCCT [2]
Enterotoxigenic
E. coli (ETEC) ST toxin
STh STp GCTAAACCAGYAGRGTCTTCAA
AATGAATCACTTGACTCTTCAAAA
CCCGGTACARGCAGGATTACAA
CATGAATCACTTGACTCTTCAAAA
TGGTCCTGAAAGCATGAATGAA
CAACACATTTTACTGCT
[2]
Salmonella enteritidis ttr CTCACCAGGAGATTACAACATGG AGCTCAGACCAAAAGTGACCATC CACCGACGGCGAGACCGACTTT [2]
Shigella spp. virG TCAGAAAGGTAATTGGCATGGA AGAACCGCGCCCAAAGA AGGGCGGAATATT [1]
Vibrio cholerae hlyA ATCGTCAGTTTGGAGCCAGT TCGATGCGTTAAACACGAAG ACCGATGCGATTGCCCAA [2]
PROCESS CONTROL
MS2 MS2g1 TGGCACTACCCCTCTCCGTATTCAC GTACGGGCGACCCCACGATGAC CACATCGATAGATCAAGGTGCC
TACAAGC
[2]
VIRUS
Adenovirus 40–41 Fiber Gene AACTTTCTCTCTTAATAGACGCC AGGGGGCTAGAAAACAAAA CTGACACGGGCACTCT [2]
Adenovirus broad
species
Hexon GCCACGGTGGGGTTTCTAAACTT GCCCCAGTGGTCTTACAT
GCACATC
TGCACCAGACCCGGGCTCAG [1]
Norovirus GI ORF 1–2 CGYTGGATGCGNTTYCATGA CTTAGACGCCATCATCATTYAC TGGACAGGAGATCGC [1]
Norovirus GII ORF 1–2 CARGARBCNATGTTYAGR
TGGATGAG
TCGACGCCATCTTCATTCACA TGGGAGGGCGATCGCAATCT [2]
Rotavirus NSP3 ACCA
TCTWCACRTRACCCTCTATGAG
GGTCACATAACGCCCCTATAGC AGTTAAAAGCTAACACTGTCAAA [2]
PROTOZOAN
Giardia duodenalis
Assemblage A
triosephosphate
isomerase (TPI)
TTCCGCCGTACACCTGTC GCGCTGCTATCCTCAACTG ATTGCGGCAAACACGTCA [1]
Giardia duodenalis
Assemblage B
triosephosphate
isomerase (TPI)
GATGAACGCAAGGCCAATAA CTTTGATTCTCCAATCTCCTTCTT AATATTGCTCAGCTCGAGGC [1]
Cryptosporidium spp. 18 s rRNA GGGTTGTATTTATTAGATAAAG
AACCA
AGGCCAATACCCTACCGTCT TGACATATCATTCAAGTTTCTG
AC
[2]
C. hominus LIB13 TCCTTGAAATGAATATTTGTGACTCG AAATGTGGTAGTTGCGGTTGAAA CTTACTTCGTGGCGGCGT [1]
C. parvum LIB13 TCCTTGAAATGAATATTTGTGACTCG TTAATGTGGTAGTTGCGGTTGAAC TATCTCTTCGTAGCGGCGTA [1]
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county, approximately 70% of all children between 12
and 23months of age have received all recommended
child disease vaccines, and it is estimated that 30% of
children experiencing diarrhoea receive timely oral rehy-
dration therapy [ORT] [18]. Two-week diarrhoeal
prevalence in Kisumu is 18%, higher than neighbouring
areas [18]. Data from the nearby Kenyan site of the Glo-
bal Enteric Multi-site Study (GEMS) [19] reported the
leading identified infectious causes of diarhhoea to be
Rotavirus, Cryptosporidium, ST-ETEC and Shigella.
Fig. 1 – CONSORT diagram
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Community health volunteer system
Kenya has been undergoing a process of decentralization,
with many areas of policy, including the health sector and
the community extension services, now the responsibility
of the County Government. The Community Health
Committee (CHC), is the health governance structure
closest to the people at the county level. Community
Health Volunteers (CHVs), who serve as frontline health
workers in this decentralized system, report to the com-
munity health committee through the Community Health
Extension Workers (CHEW) [20].
CHVs receive basic training to diagnose and treat ill-
nesses such as malaria, pneumonia, and diarrhoea; make
referrals to health facilities; provide health education;
conduct nutrition surveillance; collect vital events data;
assist with immunization and provide other aspects of
maternal and child health [21, 22]. More recently, CHVs
have been engaged in the promotion of some hygiene-
related behaviour, including community led total sanita-
tion (CLTS) and safe household water storage and treat-
ment [23]. Under the current study, we collaborated
with CHVs to design and test an intervention to reduce
infant exposure to enteric pathogens and they are in-
volved in the delivery of the intervention.
Study participants
Our primary participants are infants enrolled at the age
of 22 weeks (+/− 1 week), who currently reside in
Nyalenda A or B, and will be living there for the subse-
quent five months. Our secondary participants are pri-
mary or secondary caregivers who provide care to the
infant during the day and who are at least 18 years of
age. A primary caregiver is defined as the person who is
directly responsible for the enrolled child and a second-
ary caregiver is defined as any other person apart from
the primary caregiver who watches the child or supports
the primary caregiver.
The Safe Start intervention
Development of intervention
We followed the Behaviour Centered Design (BCD) ap-
proach to intervention development [24]. Specific quali-
tative and quantitative formative research studies were
implemented in a similar and neighbouring area of
Kisumu city. Infant faecal-oral exposure in their domes-
tic environment was assessed using structured observa-
tion of infants and caregivers, identifying low rates of
hand hygiene among caretakers and infant food as a vi-
able route of exposure to enteric pathogens that could
be mitigated by safe preparation, storage and reheating
of food [25]. Caregiver attitudes and practices in this
population and the emotional and environmental drivers
of food hygiene behaviours were assessed through struc-
tured observation and in-depth interviews with primary
and secondary caregivers [26]. Microbiological and
molecular analysis of infant food samples was used to
determine the prevalence and intensity of infant food
contamination with specific enteric pathogens implicated
in childhood diarrhoea [6]. Various known diarrhoea-
genic agents, including bacteria, viruses and protozoa,
were frequently detected with at least one enteric patho-
gen identified in 62% of infant food samples and mul-
tiple pathogens identified in 37% of infant food. A fourth
study that specifically informed Safe Start intervention
delivery explored CHV schedules, routines and capacity
to deliver behaviour change through direct observation,
interviews, and focus group discussions. This study iden-
tified a wide range of challenges, including: poor train-
ing, lack of material resources, and limited incentives to
undertake additional tasks [23].
Formative research findings led to the design of two
primary candidate intervention components designed to
improve food hygiene behaviours in the target popula-
tion. The first component consisted of hardware items
introduced at the household level to facilitate improved
food hygiene behaviours. The second component con-
sisted of motivational and educational messaging de-
signed to improve caregiver knowledge of proper food
hygiene and target the specific emotional drivers of safe
food hygiene identified in formative research. The feasi-
bility and acceptability of the two intervention compo-
nents – both independently and in combination– were
assessed and iteratively adapted using the Trials of Im-
proved Practice (TIPs) methodology [27]. Details of this
process are described in Simiyu et al. [28].
Intervention description
The final intervention was designed to target early child-
hood exposure to enteric pathogens through contami-
nated food. The intervention targets the following four
behaviours:
1. Safe hand hygiene: handwashing with soap before
food preparation and before infant feeding.
2. Safe food preparation: bringing all infant food to the
boil before any feeding event.
3. Safe storage of food: storing all infant food in sealed
containers.
4. Safe feeding: using designated utensils for infant
feeding reserved from other use.
The intervention components use two sequential and
complementary aspects of the nurture motives. The first
is the desire to care for and protect a child as they grow.
In formative research, “happy” was seen as marker of
child fitness and health. The concept of “Happy Baby”
emerged as a focal point for messaging and was
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incorporated into intervention materials. The second
commonly articulated aspect of nurture was the desire
to ensure that the child will have a successful future.
This was operationalized as messages related to a “Suc-
cessful Child” and focused on ensuring that the mother
provides the necessary foundation for future success. In
addition to messages targeting emotional drivers, the
intervention also provides the necessary foundational
knowledge about food hygiene, and associated risks, but
framed within an emic understanding of child health
and successful parenting within the communities.
The intervention is delivered in four visits (Fig. 3) in
collaboration between CHVs and specifically trained
field staff. Visit 1 is a preliminary sensitization visit, led
by participating CHVs in the weeks before children turn
six months of age. During this first visit, CHVs reiterate
existing messages regarding the importance of exclusive
breastfeeding until 6 months of age, appropriate weaning
foods, and their introduction after six months. The CHV
also introduces new topics regarding food hygiene, in-
cluding: environmental contamination, the risks associ-
ated with contaminated weaning food, and the potential
health consequences - diarrhoeal disease, growth impair-
ment, and cognitive deficits. The second visit is timed to
coincide with children turning 6 months (25 weeks) old
and introduces the “Happy Baby” aspect of the interven-
tion. This household visit is designed to be a fun and
lively experience for participating households and is led
by specifically trained field staff who are accompanied by
local CHVs. During this visit, field staff deliver a number
of products designed to enable and trigger improved
food hygiene practices, including: a baby bowl, a baby
spoon, a baby cup, a handwashing container/station, a
bottle dispenser of liquid soap (with instructions for self-
refill), two deep and two rectangular sealable storage
containers, and a branded “Happy Baby” feeding mat. In
addition, intervention households receive a “Happy
Baby” customised calendar with images that reinforce
target behaviours and reference newly provided mate-
rials. Caregivers are instructed to record diarrhoea epi-
sodes on calendars between visits, ensuring that
caretakers interact with and see messages. Visit 3 occurs
when the child is 29 weeks old. This visit, once again
lead by local CHVs, reinforces messages, discusses expe-
riences with new target behaviours, and reviews new in-
formation on food hygiene. Visit 4 occurs when the
child is 32 weeks old and introduces the “Successful
Child” component of the intervention. Successful child
images compliment “Happy Baby” materials by including
images of older children in graduation gowns and caps.
The successful child stage includes a “graduation event”
for the caregiver, including a “food hygiene pledge”, and
a forward-looking discussion about their aspirations for
the infant and how to give their child a “Safe Start” in
life. As an example of the materials, we include an image
of the “Successful Girl” calendar given to caregivers in
the intervention group (Additional file 1).
Data collection
Data are collected at three points – baseline, midline,
and endline – through survey questionnaire, structured
observation, along with stool and food sample collection
(Fig. 3). At baseline (22 weeks of age), a short survey
questionnaire is administered to the infant caregiver
covering general household information, WASH access,
infant health and animal contacts, with key details veri-
fied against the infant’s health card (e.g. date and place
of birth, vaccination status). At the same time, a stool
sample is collected from the infant for analysis (proced-
ure described below). At midline (33 weeks of age) a sec-
ond household visit is made with a structured
observation of infant food preparation and feeding by
the caregiver, and a second short questionnaire adminis-
tered. Lastly, an endline visit is completed at age 37
weeks when a stool sample is collected and a third short
questionnaire administered.
Intervention ‘fidelity’ is assessed using process evalu-
ation methods [29] to collect qualitative and quantitative
data through in-depth interviews, focus group discus-
sions and structured questionnaires with CHVs and
caregivers among a small sample of intervention and
control clusters/households. At each follow-up point,
any participant deaths are recorded along with the offi-
cial cause of death.
All personal identifiers collected, including names and
telephone numbers, will be stored separately from other,
de-identified data. All data from the surveys, stool and
environmental samples will be linked through a unique
household code that cannot be traced back to an indi-
vidual. GPS coordinates for individual households will
recorded which represents identifying data that therefore
requires careful protection. The GPS coordinates them-
selves, and the specific locations of households on maps,
will not be published or presented with results of any
analyses. All physical forms will be kept in a locked file
cabinet in a locked office to prevent unintended release
of information. All electronic data will be encrypted and
stored on secured and password protected electronic
databases.
Environmental and clinical sample collection
A stool sample is collected for each enrolled infant at
baseline (22 weeks of age) and endline (37 weeks of age),
and an infant food sample collected at midline (33 weeks
of age) [Fig. 3]. For infant stool, the infant’s caregiver is
given several unused, clean diapers and is asked to use the
diapers on the child until they defecate. Once a child has
defecated in a diaper, the caregiver folds the diaper so that
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Fig. 2 – Map showing Safe Start study areas of Nyalenda A and B (pink), two of the informal neighbourhoods around Kisumu Town in Kisumu
County, Kenya
Mumma et al. BMC Infectious Diseases         (2019) 19:1066 Page 7 of 11
the faeces is undisturbed on the interior and places the
diaper in a provided biohazard bag. This procedure is used
to prevent faeces samples from being collected off the
ground (contaminated by soil) or from out of potties used
by other children (contaminated by faeces). The bag is
stored in a cool, dark, secure place until the research team
returns to the household the next day and collects the
sample. On the day of sample collection, the enumerator
uses the scoop from the sterile collection bottle to scoop
the stool from the diaper into the bottle, labelling the con-
tainer with the date of collection and participant’s identifi-
cation number. The bottle with the stool sample is placed
in a bio hazard bag and the bag placed on ice in a cooler
box and transported to the laboratory. At the laboratory, a
lab technician sterilizes the outside of the bio hazard bag,
removes the stool collection bottle from the bag, and re-
cords the sample as received. If the infant has not defe-
cated on the day of sample collection or the stool sample
is not sufficient for collection, the enumerator informs the
parent or caregiver that they will return again the next
day. This continues for up to 5 consecutive days.
For the infant food sample, the research team collects a
sample of food cooked during the midline observation, and
again several hours later after food has been used and
stored for several hours. The caregiver is asked to place a
sample of food in a sterile WhirlPak bag by the same means
as she would feed a child (e.g. spoon, hands). Given that
levels of contamination in food may increase with time dur-
ing the day, time of collection is noted. Samples are labelled
(date, time and study identification number), placed imme-
diately into a cooler box, maintained at < 10 °C with ice
packs, and then transported to the laboratory for analysis.
Laboratory analysis
Food samples are processed by enumerating a bacterial
indicator of faecal contamination (Enterococcus). In brief,
1 ml (mL), 0.1 mL, and 0.01 mL dilutions of liquid foods
are filtered through 0.45 μm pore-size membrane filter
(Millipore Corp., Bedford, MA, USA), and the filters are
cultured overnight on Slanetz &Barley Enterococcus
Medium (OXOID CM0377). For solid foods, five grams
are homogenized with 45mL of sterile phosphate buffer
saline (PBS), and 10mL, 1 mL, and 0.1 mL dilutions are
filtered and cultured on Enterococcus agar plates. Then
the plates are incubated at 41 °C ± 0.5° for 24 h. After in-
cubation, all light and dark red colonies are counted as
Enterococcus and expressed as colony forming units
(CFU) present per gram of food sample. A 10 ml volume
of PBS used to resuspend solid food samples and wash
membrane filters is processed each day as a food nega-
tive control.
A 200 mg sample of each stool sample is measured
into a Zymo Shield Collection container and DNA and
RNA is co-extracted using the ZymoBiomics DNA/RNA
Mini kit according to the manufacture’s protocol (Zymo
Corp., CA, USA). DNA/RNA is immediately stored in a
− 20 °C freezer until transfer to the University of Iowa
for molecular analysis. A second 200mg stool sample is
Fig. 3 Intervention and Data Collection Schedule
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transferred to a labelled sterile Eppendorf tube and
stored in a − 20 °C freezer as a repository in the event
that primary samples are lost, mislabelled, or otherwise
destroyed. All stools are processed in sterilized biosafety
cabinets with laminar air flow, and one process negative
control is prepared each day by leaving a Zymo Shield
Tube open in the cabinet during stool processing, and
then processing it for DNA/RNA extraction. Pathogen
targets are detected and quantified by quantitative real-
time polymerase chain reaction using Customized Taq-
man Array Cards on a ViiA7 thermocycler (Life Tech-
nologies, USA) as previously described with the
exception of adding 300 uM bovine serum albumin
(BSA) to reduce inhibition during PCR. Outcomes are
defined as the pathogen-specific presence and concen-
tration of individual pathogens, as well as the presence
and diversity (sum of pathogen types) of all pathogens.
Concentrations of individual pathogens per gram of
stool are estimated by comparison of cycle thresholds of
pathogen specific genes against standard curves for each
reference of interest. In the event that pathogen genes
are detected in process negative controls, monoplex PCR
is used to verify that detection is true contamination. If
negative controls are contaminated, the stool samples
processed on the same day as the negative control are
considered non-determined (ND) for the related
pathogen.
Sample size calculation and analysis
Using a standard approach for calculating sample size
for cluster Randomised Controlled Trials [30] we esti-
mated the minimum detectable difference in primary
and secondary health outcome measures with a planned
total sample size of 750 children (375 intervention, 375
controls) across 50 clusters (25control/25 intervention)
and with an anticipated intra-class correlation co-
efficient (ICC) of 0.01. Our assumptions regarding base-
line/control prevalence of any enteric infection and diar-
rhoeal disease are drawn from the most recent Multiple
Indicator Cluster Survey (MICS) estimates for the preva-
lence of stunting and recent diarrhoea in Nyanza prov-
ince [18], and the Demographic and Health Surveillance
(DHS) survey national urban estimates for Kenya [31];
alongside, the national (Kenyan) and global estimates for
prevalence of any enteric infection from the Global
Enteric Multi-country Study (GEMS) [19]. In the ab-
sence of published effect size estimates for similar early
childhood interventions on enteric infection prevalence
and our assumption regarding effect size is cautiously es-
timated based on the effects on diarrhoea of different
WASH interventions [32].
For the primary outcome, with 750 infants enrolled,
and assuming a control prevalence of ≥1 of the 23
measured enteric infections of 0.7, and an intraclass
correlation coefficient (ICC) of 0.01 we would have 80%
power at a 5% level of significance to detect a minimum
difference between arms in the prevalence of ≥1 infec-
tion of 11%. For our secondary outcome, with 750 in-
fants, we would be able to detect a minimum difference
in longitudinal prevalence of caregiver reported diar-
rhoea of 7% or greater, assuming a control longitudinal
prevalence of diarrhoea of 15%.
The CONSORT Statement for cluster randomised
controlled trials will guide the analysis and presentation
of results [33]. To assess any imbalance between arms,
descriptive statistics of demographic and outcome mea-
sures (where available) will be tabulated at baseline.
All analysis will be carried out on groups as rando-
mised (‘intention to treat’). All analyses will account for
the nature of the distribution of the relevant outcome
and results will be presented as appropriate effects sizes
at 95% confidence intervals. We account for clustering
by using generalised estimating equations (GEE) and
adjust for baseline differences in groups by including the
cluster mean of our outcome at baseline as a covariate
in statistical models. For all analyses, unadjusted and
adjusted results will be presented, with covariates in
adjusted analyses specified a priori.
Randomisation
Randomisation was undertaken remotely by the Clinical
Trials Unit at the London School of Hygiene & Tropical
Medicine (LSHTM). The unit of randomisation is the
CHV catchment cluster, and, in discussion with the
Ministry of Health for Kisumu County, the participating
50 clusters were selected from the 94 eligible clusters in
the study neighbourhoods, with eligibility determined by
the presence of an “active” CHV. The 50 active clusters
were then randomly allocated 1:1 into two trial arms.
Blinding
This is a public health intervention seeking to change
specific behaviours through direct engagement with
participants such that blinding of participants to their al-
location was not deemed possible. Randomisation of
clusters was done remotely; enumerators, principal in-
vestigator, and trial statistician were blinded to alloca-
tion. The trial statistician will conduct final analyses
blind to allocation.
Coordinating committees
The Trial Management Group includes representatives
from each partner organisation (GLUK, Iowa University
and LSHTM) chaired by the Principal Investigators (JM
and OC). Modifications required to the protocol (inter-
vention, participants, study design, analysis methods, or
outcomes) during the study will be approved by the
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LSHTM Research Ethics Committee prior to implemen-
tation and the new information registered on the trial
registry (clinicaltrials.gov). Need and frequency of audits
for trials is independent of the investigators and is deter-
mined using a risk-based approach.
Adverse events
The trial is monitored for adverse events and all re-
ported adverse events are documented and reports are
compiled on a quarterly basis. The principal investiga-
tors (JM and OC) will review any reported severe ad-
verse events to assess the level of relatedness to
intervention and take appropriate action.
Limitations
We had initially intended for the Safe Start intervention
to be delivered exclusively by CHVs to demonstrate
more directly the scalability of such an intervention
within the existing health system structure and resource
envelope. However, findings from our formative work
demonstrated that such an approach would likely place
undue burden on CHVs in the context of a research
project. Although delivered by specialized field workers
employed for the purposes of this study, our interven-
tion is still considered to be deliverable within the CHV
system and has been endorsed as such by the Ministry
of Health for Kisumu County.
Discussion
The goal of the ‘Safe Start’ intervention is to demon-
strate that low cost, locally appropriate food hygiene
interventions which target child caregivers of weaning
infants can reduce foodborne exposure to enteric
pathogens and the resulting infection and disease. Our
intervention, informed by extensive formative research
with infants, caregivers, health extension workers and
discussion with the local Ministry of Health, has the po-
tential to be scaled up if proven to be effective.
Trial status
Protocol version number and date: Version 1, March 01,
2018.
Date recruitment began: March 26th, 2018.
Approximate date when study will be completed: No-
vember 30th, 2019.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12879-019-4657-0.
Additional file 1. Intervention materials, the “Successful Girl” calendar.
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